These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21422632)

  • 1. Hemodialysis-associated pseudoporphyria resistant to N-acetylcysteine.
    El Kabbaj D; Laalou A; Alouane Z; Bahadi A; Oualim Z
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):311-4. PubMed ID: 21422632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of haemodialysis-associated pseudoporphyria successfully treated with oral N-acetylcysteine.
    Cooke NS; McKenna K
    Clin Exp Dermatol; 2007 Jan; 32(1):64-6. PubMed ID: 17305908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful outcome of haemodialysis-induced pseudoporphyria after short-term oral N-acetylcysteine and switch to high-flux technique dialysis.
    Massone C; Ambros-Rudolph CM; Di Stefani A; Müllegger RR
    Acta Derm Venereol; 2006; 86(6):538-40. PubMed ID: 17106603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudoporphyria induced by dialysis treated with oral N-acetylcysteine.
    Guiotoku MM; Pereira Fde P; Miot HA; Marques ME
    An Bras Dermatol; 2011; 86(2):383-5. PubMed ID: 21603831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudoporphyria associated with hemodialysis treated with N-acetylcysteine.
    Tremblay JF; Veilleux B
    J Am Acad Dermatol; 2003 Dec; 49(6):1189-90. PubMed ID: 14639417
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudoporphyria in a hemodialysis patient successfully treated with oral glutamine.
    Azak A; Yenigün E; Koçak G; Huddam B; Kahve B
    Hemodial Int; 2013 Jul; 17(3):466-7. PubMed ID: 23461815
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pseudoporphyria cutanea tarda in patients undergoing hemodialysis for chronic renal insufficiency. II].
    Aste N; Cogoni G; Anni MS; Iannelli P; Usai E; Biggio P
    G Ital Dermatol Venereol; 1982; 117(1):23-6. PubMed ID: 7186878
    [No Abstract]   [Full Text] [Related]  

  • 8. N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients.
    Hsu SP; Chiang CK; Yang SY; Chien CT
    Nephron Clin Pract; 2010; 116(3):c207-16. PubMed ID: 20606481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodialysis-induced pseudoporphyria successfully treated with glutathione.
    Kasuya A; Hashizume H; Hirakawa S; Tokura Y
    Eur J Dermatol; 2012; 22(1):137-8. PubMed ID: 22217550
    [No Abstract]   [Full Text] [Related]  

  • 10. [Porphyria cutanea tarda, pseudoporphyria and hemodialysis of chronic renal failure patients].
    Köstler E; Heinicke HJ
    Z Gesamte Inn Med; 1986 Jan; 41(2):50-2. PubMed ID: 3953126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyria cutanea tarda associated with chronic renal disease and hemodialysis.
    Poh-Fitzpatrick MB; Masullo AS; Grossman ME
    Arch Dermatol; 1980 Feb; 116(2):191-5. PubMed ID: 7356350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pseudoporphyria cutanea tarda: eventual pathogenetic role of the extracorporeal circuits].
    Aste N; Altieri P; Bolasco PG; Barracca A; Biggio P
    G Ital Dermatol Venereol; 1985; 120(6):397-400. PubMed ID: 4086050
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of porphyria cutanea tarda associated with hemodialysis in chronic renal failure].
    Toriyama F; Nonaka S; Murayama F; Irifune H; Ohgami T; Kakimoto S; Yoshida H
    Nihon Hifuka Gakkai Zasshi; 1987 Oct; 97(11):1189-92. PubMed ID: 3444084
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of vitamin E and N-acetylcysteine on intracellular oxidative stress in T lymphocytes in children treated with dialysis].
    Zaniew M; Zachwieja J; Warzywoda A; Stefaniak E; Runowski D; Lewandowska-Stachowiak M
    Wiad Lek; 2005; 58 Suppl 1():58-65. PubMed ID: 16060087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis-associated pseudoporphyria successfully treated with vitamin D. Report of two cases.
    Pranteda G; Bottoni U; Tayefeh Jafari M; Pranteda G; De Micco S; Muscianese M; Menè P
    G Ital Dermatol Venereol; 2015 Jun; 150(3):327-9. PubMed ID: 25946676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodialysis-related porphyria cutanea tarda--treatment failure with charcoal hemoperfusion.
    McColl KE; Simpson K; Laiwah AY; Thompson GG; McDougall A; Moore MR
    Photodermatol; 1986 Jun; 3(3):169-73. PubMed ID: 3529056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific skin disorders in chronic kidney failure with hemodialysis].
    Fujisawa S; Morishima T
    Nihon Rinsho; 1992 Jan; 50 Suppl():873-8. PubMed ID: 1578781
    [No Abstract]   [Full Text] [Related]  

  • 18. N-Acetylcysteine in the prevention of ototoxicity.
    Tepel M
    Kidney Int; 2007 Aug; 72(3):231-2. PubMed ID: 17653228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pseudoporphyria cutanea tarda in hemodialysis patients].
    Thivolet J
    Hautarzt; 1979 Mar; 30(3):154-7. PubMed ID: 437971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis.
    Anderson KE; Goeger DE; Carson RW; Lee SM; Stead RB
    N Engl J Med; 1990 Feb; 322(5):315-7. PubMed ID: 2104958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.